Florida Pharmacy Today July 2018 by Florida Pharmacy Today

The Official Publication Of The Florida Pharmacy Association JULY 2018

2018-2019 FPA PRESIDENT

ANGELA GARCIA

Buying, Selling or Starting a Pharmacy? We can help you practice pharmacy your way. Our dedicated and experienced ownership consultants can help you achieve your goals. From planning and financing to site selection and product mix, we deliver answers you can trust. Set your pharmacy-ownership goals and point your future in the right direction with the help of RxOwnership. Visit RxOwnership.com or call 800.266.6781 today!

RxOwnership.com

florida PHARMACY TODAY

VOL. 81 | NO. 7 JULY 2018 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION

HB 21 Features Departments A Summary of the Florida Controlled Substances Law of 2018 4 Advertisers

Shelby Swartzentruber, Pharm.D. Candidate 2019

Handbook of Association Information Take part in the full benefits of Florida Pharmacy Association membership. Included is information you can use to participate in legislative activities Controlled Substance Prescribing (Continued) and information you need to contact association leadership.

4 Calendar Pain 5 Acute President’s Viewpoint

7 Acute Executive Insight pain is now defined as the “normal, predicted,

If a practitioner prescribes a Schedule II opioid for the #1 Club ..............................................................16 physiological, and time-limited response to an adverse treatment of pain other than acute pain (chronic 36 chemical, Buyer’s Guide Address ............................................................8 FPA Officer thermal, or mechanical stimulus associated with nonmalignant pain or pain and that is excluded from the Director ........................... 17 surgery, trauma, or acute illness.” ThisStaff does ....................................................................8 not include: definition of acute pain),Nominations. the practitioner must indicate “Non-Acute Pain” the prescription. • Cancer FPAon Constitution. ......................................18 Mission Statement..................................12 • Terminal illness ByLaws................................................ 22 Past Presidents .......................................12 Additionally, if FPA a practitioner prescribes a Schedule II • Palliative care FPA House of Delegates controlled substance for the treatment of pain related Organizational Chart • Serious traumatic injury with Injury Severity Score of ............................13 ByLaws. . ......................................................... 29 to a traumatic injury with a severity score of 9 or 9 or greater Code of Ethics ...........................................14 greater, the practitioner must prescribe an emergency CE Requirements .................................. 32 • Chronic Non-Malignant pain (implied) opioid antagonist along with the controlled substance. Unit Associations ...................................15 Executive Committee ........................... 6

CE Calendar ............................................... 35

• The legislature did not limit this requirement to .............................................................15 Note: the FMA and FCEP tried to addHistory “pain related to opioid-only Schedule II controlled substances major surgery” to this without success. The above are the • FMA is seeking guidance from the boards for an only exceptions to the definition of acute pain. update as to whether this is just for Schedule II opioids or every Controlled Schedule II controlled substance HB 21: A Summary of the Florida Controlled Substance Prescribing (into effect July 2018)

Substances LawLastly, of 2018 applicable healthcare regulatory boards (Board

HB21 states that E-FORCSE (Electronic Florida Online Reporting of Controlled Substances Evaluation Program) must be consulted prior to prescribing or dispensing any controlled substance for patients that are 16 years or older. The only exception is for non-opioid Schedule V medications (examples being pregabalin or lacosamide).

If the database is not accessible, the practitioner may move forward with prescribing/dispensing the medication, but must document the reason the database was not consulted and can’t prescribe/dispense more than a 3 day supply. If a prescription is written for a Schedule II opioid, the quantity is limited to no more than 3 days when prescribed to treat acute pain. If a practitioner determines that a longer duration is medically necessary, this limit can be increased to 7 days with proper documentation: • “Acute Pain Exception” is indicated by the practitioner on the prescription • The prescriber documents in the medical records that the medical condition and lack of alternative treatment options explains the deviation from the 3 day supply limit

of Medicine and Board of Osteopathic Medicine) are required to create standards of practice for the treatment of acute pain. These guidelines should include the following components (they are forthcoming): • Evaluation of a patient • Creation and maintenance of a treatment plan • Obtain informed consent and treatment agreement • Review of the treatment plan and consultation • Medical record review • Compliance with controlled substance laws and regulations

JULY 2018

FPA Calendar 2018

AUGUST

of the Florida Pharmacy Today Journal OCTOBER

5-8

35th Annual Southeastern Gatherin’ Destin

2 - 3

Florida Board of Pharmacy Meeting Ft. Lauderdale

7-8

Florida Board of Pharmacy Meeting Orlando

6 - 7

Midyear Clinical Conference Kissimmee

25-26 FPA Committee, Council and Board of Directors meeting Orlando

6 - 7

Midyear Nuclear Conference Kissimmee

6 - 9

NCPA Annual Meeting Boston, Mass

SEPTEMBER 1

Deadline for the receipt of FPA nomination for office

Labor Day - FPA office closed

8-9

Clinical Conference Miami

Mission Statements: The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Phar-

macy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on

pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

NOVEMBER 22-23 Thanksgiving - FPA office closed DECEMBER 1 - 2

Regulatory and Law Conference Sarasota

11 - 12 Florida Board of Pharmacy Meeting Orlando

For a complete calendar of events go to www.pharmview.com Events calendar subject to change

of the Florida Pharmacy Today Board of Directors The mission of the Florida Pharmacy Today

Board of Directors is to serve in an advisory capacity to the managing editor and execu-

tive editor of the Florida Pharmacy Today

Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities.

The Board of Directors also serves to motivate the Florida Pharmacy Association members

to secure appropriate advertising to assist the CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE Continuing Education as part of the required 30 hours’ general education needed every license renewal period. There is a new 2 hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. Pharmacists should have satisfied all continuing education requirements for this biennial period by September 30, 2019 or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by December 31, 2018. For Pharmacy Technician Certification Board Application, Exam Information and Study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.pharmview.com CONTACTS FPA — Michael Jackson (850) 222-2400 FSHP — Tamekia Bennett (850) 906-9333 UF — Kristin Weitzel (352) 273-5114 FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300 DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.

4 |

FLORIDA PHARMACY TODAY

Journal in its goal of self-support.

Advertisers Rx OWNERSHIP.................................................. 2 EPIC PHARMACY NETWORK....................... 14 KAHAN & ASSOCIATES................................. 20 PHARMACISTS MUTUAL.............................. 21 PQC...................................................................... 32 SHARPS, INC..................................................... 34

E-MAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com

The President’s Viewpoint ANGELA S. GARCIA, PHARMD/MPH, CPH

The Power of WE

n every aspect of life – professional or personal - I believe in the power of relationship. Without a relationship, there is no investment. There is no accountability. There is no legacy. Growing up FPA is a term that I have adopted in my approach to membership with the Florida Pharmacy Association … and share regularly with others. I “grew up” in the FPA, first as a student, then as a new practitioner and have since grown in service from ad hoc committees to councils, and for the past year as an officer. What I have learned in my life outside of pharmacy, is that strong foundations (relationships) are what set the expectation for others and for yourself. Within pharmacy, technicians, student pharmacists, new practitioners and those practicing for years, can identify with specific relationships that impacted us in a way we never expected, and have endured over time. These relationships have been invested with our patients, other members of pharmacy practice and with providers outside of pharmacy. The mentorship I received Growing Up FPA has cultivated a deep desire to invest in others through service, mentorship, leadership and volunteerism. It is my desire to serve as a strong leader, taking on challenges and connecting with others. In order to do this, surrendering what serves my own best interests is necessary so that I can identify with what is going to open doors and connect others to a common goal. This is the premise for the 2018-2019 presidential term, The Power of WE. Investing in others builds loyalty and that loyalty can be a driving force to be reckoned with. I cannot imagine practicing as a pharmacist in any capacity and not

having a connection to your state association. This disconnect is what we have to openly recognize in order to understand why it exists. Once we achieve this, then we are in a position to take action to change the perception and drive the desire for others to be in relationship with us. Donald McGannon said, “Leadership is an action, not a position,” and this is such a profound truth for thriving associations to embrace at every level. It is up to us to cultivate the kind of leadership we want to see in others, Angela S. Garcia, PharmD, MPH, CPh

I am excited to work on the new strategic plan with the FPA Leadership Team. and the leadership I have been blessed to be groomed and pruned by through my own journey with the FPA has led me to the path of serving as the 20182019 FPA president. I am excited to work on the new strategic plan with the FPA Leadership Team. The diversity of our FPA staff, officers, regional directors, chairs and members of the Councils will allow us to maintain a strong sense of history, but will concurrently allow us to really examine who we are as a profession within this state and where we see ourselves going over the next five years. Areas we are bringing attention and focus to include: ■■ Performing critical-needs assess-

■■

ments for our pharmacy workforce and enhancing the educational programming opportunities and trainings that will push our Association members forward in practice at every level; Reconnecting with strong grassroots advocacy efforts by building legislative relationships in our local communities in order to put forth our priorities rather than responding to those that don’t serve our best interest under the guidance of our Adams Street Advocates team; and Identifying ways to strengthen our leadership, whether elected, appointed, volunteer or in recognition for past leadership service, to increase our capacity to lead others, network and collaborate in meaningful ways with other health professions, as well as reinvest in and support the outstanding staff we have for the Association.

The leadership team this year is full of incredible energy and it is an honor JULY 2018

2018-19 FPA Board of Directors The Florida Pharmacy Association gratefully acknowledges the hard work and dedication of the following members of the FPA leadership who work diligently all year long on behalf of our members.

Suzanne Wise.....................................................................................................Board Chair Angela Garcia...............................................................................................FPA President Ashley Huff.................................................................................................... FPA Treasurer David Mackarey.......................................................................................President-Elect Jeanette Connelly...................................................................Speaker of the House Gary Koesten..................................................................Vice Speaker of the House Charzetta James.................................................................................. FSHP President Joyanna Wright................................................................................... Region 1 Director Neil Barnett............................................................................................Region 2 Director Dean Pedalino.......................................................................................Region 3 Director Cheryl Rouse.........................................................................................Region 4 Director Melissa Ruble........................................................................................Region 5 Director Barbara Beadle...................................................................................Region 6 Director Paul Delisser.......................................................................................... Region 7 Director Ramy Gabriel.........................................................................................Region 8 Director Mitchell Fingerhut.............................................................................Region 9 Director Julie Burger........................................................................................Technician Member

Florida Pharmacy Today Journal Board Chair.............................................................. Carol Motycka, motycka@cop.ufl.edu Vice Chair....................................................Cristina Medina, cmmedina@cvs.com Treasurer.........................................................Eric Jakab, ericjakab@hotmail.com Secretary................................................................... Stuart Ulrich, stuarx@aol.com Member.................................................. Michael Finnick, michaelfinnick@ufl.edu Member.......................................................Matt Schneller, schnem18@gmail.com Member..........................................Teresa Tomerlin, teresapharmd@cfl.rr.com Member............................................Greta Pelegrin, gretapelegrin@yahoo.com Technician Member........................Julie Burger, julieburger133@gmail.com Executive Editor................Michael Jackson, mjackson@pharmview.com Managing Editor...................Dave Fiore, dave@fiorecommunications.com Journal Reviewer....................... Dr. Melissa Ruble, mruble@health.usf.edu Journal Reviewer....................................Dr. Angela Hill, ahill2@health.usf.edu

6 |

FLORIDA PHARMACY TODAY

to stand with them to serve the Association and the profession of pharmacy in the state of Florida. We will harness the talents of an incredible team of servant leaders this year as we create exciting changes for ourselves and our membership in order to draw in those not yet members of the FPA. The example we set for our Association will reflect the strength of pharmacy in patient care outcomes and as members of the health care team. Shedding light on dark corners and facilitating conversations with key stakeholders across public health and the health care system will allow us to initiate some incredible levels of change; change that is necessary to keep us viable as an organization and in charge of our own profession. WE are coming together to change our perception. WE are coming together to serve the best interests of our patients. WE are coming together to stand united to advance our profession and practice. WE are increasing the visibility of the impacts we make in every level of health care. WE are positioning ourselves to be seen, heard, and our presence felt in every community we represent. It is imperative that we shift in our thinking and actions from “what’s in it for me, what’s relevant to me, what affects me…” to what is the most that can be achieved through the Power of WE. n

JOIN TODAY!

MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION |

Executive Insight BY MICHAEL JACKSON, RPH MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION

ISRA CRAVEN, PHARMD CANDIDATE 2018

The Future of Pharmacy: The Good, the Bad, and the Green

ne of the surpassing benefits of being in the pharmacy profession is the dynamics of the profession itself. As a pharmacist, you have a choice in what direction you want to proceed with your career. Many new pharmacists go straight into community practice, which is going through a number of its own changes. By now we all have heard about the new wave of technology that is hitting pharmacies across the country; telepharmacy. What is telepharmacy you may ask? Practically speaking, telepharma-

The good part is that we have a new age of technology which is creating practices that are more accessible to patients in the United States. cy can be defined as the provision of pharmacy services through telecommunication.2 The Model Act of the National Association of Boards of Pharmacy provides a broad framework for understanding the pharmacy services that can be provided using telepharmacy. The Model Act defines the “practice of telepharmacy” as “the provision of pharmacist care

by registered pharmacies and pharmacists located within US jurisdictions through the use of telecommunications or other technologies to patients or their agents at distances that are located within US jurisdictions.” Pharmacist care is “the provision by a pharmacist of patient care activities … with or without the dispensing of drugs or devices, intended to achieve outcomes related to the cure or prevention of a disease, elimination or reduction of a patient’s symptoms, or arresting or slowing of a disease process.”4 The Model Act also defines “coordinating pharmacy,” “remote pharmacy,” and “remote dispensing site.” Remote pharmacies are staffed by a pharmacist, intern or pharmacy technician. Remote dispensing sites are automated dispensing kiosks located within various institutional facilities or clinics. Remote pharmacies and remote dispensing sites are all linked to coordinating pharmacies “via a computer system and/or a video/auditory communication system.”4 The first state to regulate telepharmacy was North Dakota. In 2001, the state’s Board of Pharmacy promulgated rules for a telepharmacy pilot program in an effort to combat the closure of pharmacies in rural areas. Under the program, pharmacies could operate remote sites without the physical presence of a pharmacist, so long as the pharmacy maintained a central site staffed by a pharmacist to whom the remote site was connected through “computer link, audio link, or video link telecommunication.”1 The next year, the North Dakota Telepharmacy Project used 4 central pharmacies to serve 6 remote pharmacy

Isra Craven, PharmD Candidate 2018, FPA intern attending Florida A&M University College of Pharmacy and Pharmaceutical Sciences

Michael Jackson, B.Pharm

JULY 2018 |

FPA STAFF Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200

Director of Continuing Education Tian Merren-Owens, ext. 120

Educational Services Office Assistant Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110 Accounting Coordinator Ashley Gandy ext. 211

FLORIDA PHARMACY TODAY BOARD Chair..................................... Carol Motycka, St. Augustine Vice Chair................................Cristina Medina, Hollywood Treasurer...........................................Eric Jakab, Gainesville Secretary.........................Stuart Ulrich, Boynton Beach Member............................... Michael Finnick, Jacksonville Member...............................................Matt Schneller, Tampa Member...................................Teresa Tomerlin, Rockledge Member..............................................Greta Pelegrin, Hialeah Technician Member.................Julie Burger, Pensacola Executive Editor.........Michael Jackson, Tallahassee Managing Editor.........................Dave Fiore, Tallahassee

This is a peer-reviewed publication. ©2018 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board. FLORIDA PHARMACY TODAY, Annual subscription - United States and foreign, Individual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax. FLORIDA PHARMACY ASSOCIATION

610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web Address: http://www.pharmview.com 8 |

FLORIDA PHARMACY TODAY

sites, and the success of that program led to the permanent implementation of telepharmacy rules by the Board of Pharmacy in 2003.2 In Colorado, an unlicensed pharmacy technician may provide services at a remote telepharmacy site without the direct, in-person supervision of a licensed pharmacist, but only if a licensed pharmacist is connected to the remote site via telecommunication equipment and is readily available to consult with and assist the pharmacy technician in performing the tasks associated with telepharmacy dispensing.1 On one hand, telepharmacy can increase access to pharmacy services in rural communities that are experiencing a shortage of pharmacists, as highlighted by the North Dakota Telepharmacy Project. Pharmacies can also use telepharmacy services to supplement the medical community’s use of telemedicine to combat perceived future primary care provider shortages in rural America. On the other hand, technology continues to develop at a rapid speed. In this device-filled world, pharmacists and patients are becoming more comfortable with mobile health delivery. As telepharmacy is getting more and more popular, in like manner remarkably the medicinal marijuana dispensaries are as well. I recently visited a dispensary in order to get a better understanding of how the facility really operated. When I

first walked in, there were only two employees working. A young woman at the front desk and someone that takes you to the back to “fill” the prescription. I asked what their credentials were. Their response was a high school diploma. As a future pharmacist, this is concerning. Ask health care providers, this should be concerning to us all. How is it called medical marijuana, when you have an absence of qualified medical supervision? If you have watched the news or read a newspaper recently, I am sure that you have noticed that America is going through an opioid crisis, which the health care community is well aware of. Every day, more than 115 people in the United States die after overdosing on opioids.3 The misuse and addiction to opioids—including prescription pain relievers, heroin and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion per year, including the costs of health care, lost productivity, addiction treatment and criminal justice involvement.3 But unlike opioids, marijuana has little addiction potential, and virtually no deaths from marijuana overdose have been reported in the United States.5 In order to evaluate whether medical marijuana could function as an effective and safe alternative to opioids, researchers looked at whether opioid prescriptions were lower in states that had active medical cannabis laws and whether those states that enacted these laws during the study period saw reductions in opioid prescriptions.3 In fact, they did find that opioid prescriptions were significantly lower in states that had enacted medical cannabis laws.

The team that looked at Medicaid patients also found that the four states that switched from medical use only to recreational use—Alaska, Colorado, Oregon and Washington saw further reductions in opioid prescription.3 According to Heferi Wen, assistant professor of health management and policy at the University of Kentucky and a lead author on the Medicaid study. “We saw a 9% or 10% reduction (in opioid prescriptions) in Colorado and Oregon,” Wen said “And Alaska and Washington, the magnitude was a little bit smaller but still significant.” The first state in the United States to legalize marijuana for medicinal use was California, in 1996. 5 Since then, 29 states and the District of Columbia have approved some form of legalized cannabis. All of these states include chronic pain -- either directly or indirectly -- in the list of approved medical conditions for marijuana use, according to Bradford. The method of procurement also had a significant impact on opioid prescription patterns. States that permitted medical dispensaries—regulated shops that people can visit to purchase cannabis products—had 3.742 million fewer opioid prescriptions filled per year under Medicare Part D, while those that allowed only home cultivation had 1.792 million fewer opioid prescriptions per year.5 As we have all noticed, there is a lot of disruption in the pharmacy profession. The good part is that we have a new age of technology which is creating practices that are more accessible to patients in the United States. Many phar-

macies are open 24 hours daily and seven days a week. Telepharmacy services could be a benefit for those patients that are unable to physically make it to the pharmacy, though many within our industry have called into question how a pharmacy can safely operate and be in full compliance with Florida’s complex rules and regulations absent the physical presence of a licensed pharmacist. Medical marijuana is quickly becoming a new alternative health care service that pharmacy should have a role in. Society is acknowledging that opi-

toring program. The green part is the process of medicinal marijuana being studied more and more. Debate should begin with how pharmacists can be a part of this new alternative health care option for patients. Why shouldn’t a pharmacist be a part of this option of providing health care services using medical marijuana when prescribing practitioners are engaged, patients are coming to pharmacies for standard care services and going to medical marijuana dispensaries for oth-

oid misuse is a public health care problem. The bad part of being a pharmacist now a days is that we are (a) in the center of this new opioid crisis in America, (b) having to come to the realization of the use and purpose of telepharmacy services and (c) pharmacists are not included in the medical marijuana debate. The fact is that we, as professionals, have limited control on how patients are abusing their opioid medication which creates a new standard of care. We can enhance that control with the use of the prescription drug moni-

er health care services that are not known to the pharmacist. With evidence showing declining use of opioids and concurrent use of medical marijuana, it seems that the end point ought to help alleviate the opioid crisis that has hit America substantially. So, if the issue is pharmacists should not be directly involved in medical marijuana services because of restrictions on federal laws, then how about a telepharmacists providing consultant services to medical marijuana dispensaries? n

References

1 Draft ASHP statement on telepharmacy. American Society of Health-System Pharmacists website. http://www.ashp.org/ doclibrary/bestpractices/draftdocs/draftstatementtelepharmacy.aspx. Accessed May 14, 2018. 2 APhA policy: Telemedicine/telehealth/telepharmacy. American Pharmacists Association website. http://www.pharmacist.com/ policy/telemedicinetelehealthtelepharmacy-16. Accessed May 14, 2018. 3 CDC/NCHS, National Vital Statistics System, Mortality. CDC Wonder, Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://wonder.cdc.gov. Accessed May 14, 2018. 4 Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy. National Association of Boards of Pharmacy website. http://www.nabp.net/publications/assets/ModelAct.doc. Published August 2012. Accessed May 17, 2018. 5 Legal Marijuana Could Help Offset Opioid Epidemic Mark Lieber–https://www.cnn.com/2018/04/02/health/medical-cannabislaw-opioid-prescription-study/index.html. Accesed May 12, 2018. JULY 2018

HB 21

A Summary of the Florida Controlled Substances Law of 2018 Shelby Swartzentruber, Pharm.D. Candidate 2019

Acute Pain

Controlled Substance Prescribing (Continued)

Acute pain is now defined as the “normal, predicted, physiological, and time-limited response to an adverse chemical, thermal, or mechanical stimulus associated with surgery, trauma, or acute illness.” This does not include: • Cancer • Terminal illness • Palliative care • Serious traumatic injury with Injury Severity Score of 9 or greater • Chronic Non-Malignant pain (implied)

If a practitioner prescribes a Schedule II opioid for the treatment of pain other than acute pain (chronic nonmalignant pain or pain that is excluded from the definition of acute pain), the practitioner must indicate “Non-Acute Pain” on the prescription.

Note: the FMA and FCEP tried to add “pain related to major surgery” to this without success. The above are the only exceptions to the definition of acute pain. Controlled Substance Prescribing (into effect July 2018) HB21 states that E-FORCSE (Electronic Florida Online Reporting of Controlled Substances Evaluation Program) must be consulted prior to prescribing or dispensing any controlled substance for patients that are 16 years or older. The only exception is for non-opioid Schedule V medications (examples being pregabalin or lacosamide). If the database is not accessible, the practitioner may move forward with prescribing/dispensing the medication, but must document the reason the database was not consulted and can’t prescribe/dispense more than a 3 day supply. If a prescription is written for a Schedule II opioid, the quantity is limited to no more than 3 days when prescribed to treat acute pain. If a practitioner determines that a longer duration is medically necessary, this limit can be increased to 7 days with proper documentation: • “Acute Pain Exception” is indicated by the practitioner on the prescription • The prescriber documents in the medical records that the medical condition and lack of alternative treatment options explains the deviation from the 3 day supply limit

FLORIDA PHARMACY TODAY

Additionally, if a practitioner prescribes a Schedule II controlled substance for the treatment of pain related to a traumatic injury with a severity score of 9 or greater, the practitioner must prescribe an emergency opioid antagonist along with the controlled substance. • The legislature did not limit this requirement to opioid-only Schedule II controlled substances • FMA is seeking guidance from the boards for an update as to whether this is just for Schedule II opioids or every Schedule II controlled substance Lastly, applicable healthcare regulatory boards (Board of Medicine and Board of Osteopathic Medicine) are required to create standards of practice for the treatment of acute pain. These guidelines should include the following components (they are forthcoming): • Evaluation of a patient • Creation and maintenance of a treatment plan • Obtain informed consent and treatment agreement • Review of the treatment plan and consultation • Medical record review • Compliance with controlled substance laws and regulations

Pain Management Clinic Registration In October 2010, Florida Statues required painmanagement clinics to register with the Florida Department of Health. Pain-management clinics included facilities that advertise any type of pain management services or medical practices where a majority of patients are prescribed controlled substances for the management of chronic nonmalignant pain. Key Takeaway Points for Physicians and Pharmacists There were a few exceptions to facilities that did not have to register as pain-management clinics, such as facilities that • Schedule II opioid prescriptions are limited to 3 provide primarily surgical services, those that do not days when prescribed for acute pain prescribe controlled substances for the treatment of pain, and many others. HB21 now requires that these exceptions • When a patient needs more than 3 days of a Schedule II opioid prescription, “Acute Pain apply to the Florida Department of Health for a certificate Exception” must be written on the prescription and of exemption. documentation must be in the patient’s medical record verifying the patient’s medical condition and lack of alternatives • Acute pain exceptions are limited to a 7 day supply • E-FORCSE must be consulted prior to prescribing/dispensing a controlled substance to a patient that is 16 years of age and older • Emergency opioid antagonists must be prescribed for Schedule II controlled substances that are prescribed for the treatment of pain related to a Controlled Substance Prescribing Continuing Education traumatic injury with a severity score of 9 or (Starts for renewals on Jan 2019) greater (accompanying Rx must have “NonAcute Pain” written on prescription…see below) Each practitioner that is registered with the DEA and Schedule II controlled substances that are • authorized to prescribe controlled substances must take a 2 prescribed for the treatment of pain other than hour prescribing controlled substance continuing acute pain (chronic nonmalignant pain or pain that is education course. This pertains to allopathic physicians, excluded from the definition of acute pain) must osteopathic physicians, podiatrists, dentists, and have “Non-Acute Pain” indicated on the optometrists that are registered with the DEA. prescription • Advanced registered nurse practitioners and physician assistants already have to take a 3-hour course on controlled substance prescribing References: • The course must be accredited and taken from a 1. Scott S. “Florida’s New Law on Controlled Substance Prescribing.” Florida Medical Association. June 2018. statewide professional association of physicians: 2. Image 1: https://www.pbs.org/newshour/health/back The Florida Medical Association pain-industry-taking-patients-unhealthy-ride  The Florida Osteopathic Medical Association 3. Image 2: https://openclipart.org/search/?query=book  The Florida Academy of Family Physicians 4. Image 3: http://www.clker.com/clipart-pink The Florida Psychiatric Society medication.html • The course must be taken by January 31, 2019 and then before each license renewal

JULY 2018 |

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FPA Past Presidents 1887-88 Dr. Hy Robinson

1928-29 F. B. Stephens

1888-89 Dr. J. D. Palmer

1929-30 William Emrich

1889-90 H. C. Cushman

1930-31 H. W. Childs

1890-91 W. A. Rawls

1931-32 J. H. Haughton

1891-92 A. E. Philips

1932-33 E. O. Purcell

1892-93 N. Woolridge

1933-34 John K. Clemmer

1893-94 T. S. Chalker

1934-35 Don S. Evans

1894-95 F. P. McElory

1935-36 Victor Wray

1895-96 W. I. Woodman

1936-37 George O. Taylor

1896-97 J. A. Conover

1937-38 R. Q. Richards

1904-05 J. C. Abernathy

1938-39 George Moore

1905-06 Thomas Clarke

1939-40 S. F. Harris

1906-07 J. M. Stansfield

1940-41 L. H. Penberthy

1907-08 D. W. Ramsaur

1941-42 J. Emmett Brown

1908-09 W. S. Oppenheimer

1942-46 H. B. Douglas

1909-10 J. W. Bodiford

1946-47 C. G. Hamilton

1910-12 W. D. Jones

1947-48 A. B. Ware

1912-13 Macon Thornton

1948-49 D. M. Weaver

1913-14 Leroy Cotter

1949-50 E. E. Bludworth

1914-16 M. M. Taylor

1950-51 Ed J. Pierce

1916-17 H. H. Dâ&#x20AC;&#x2122;Alemberte

1951-52 Euless Watford

1917-18 W. A. Rawls

1952-53 Clyde Morris

1918-19 Marshall Bize

1953-54 A. Wm Morrison

1919-20 J. S. Jewett

1954-55 John L. McDonald

1925-26 J. R. West

1955-56 Francis Walpole

1926-27 J. K. Atwood

1956-57 Wesley D. Owens

1927-28 Cliff Smith

Jacksonville, FL

FLORIDA PHARMACY TODAY

1957-58 Grover F. Ivey* Orlando, FL

1958-59 James Love*

Delray Beach, FL

1959-60 Rufus I. Thomas*

New Smyrna Beach, FL

1960-61 Lucien W. Watson Marianna, FL

1961-62 L. W. Harrell* Palatka, FL

1962-63 Dan Davis* Miami, FL

1963-64 Walter Griffin* Jacksonville, FL

1964-65 Freeman Oikle* Miami, FL

1965-66 Felix Donatelli Lakeland, FL

1966-67 Arnold Albert*

Orlando, FL

1967-68 Harold S. Osteen Jacksonville, FL

1968-69 John W. White* Tallahassee, FL

1969-70 Neil Bitting* Ocala, FL

1970-71 Sidney Simkowitz* Miami, FL

1971-72 Mark Sullivan* Tallahassee, FL

1972-73 George B. Browning Melbourne, FL

1973-74 John W. Davies Orlando, FL

1974-75 Bernard J. Cimino* Tampa, FL

1975-76 William Nestor

Palm Beach Gardens, FL

1976-77 Gilbert N. Weise, Sr. Jacksonville, FL

1977-78 Robert T. Showerman* St. Petersburg, FL

1978-79 John Stadnik*

Miami Springs, FL

1979-80 Lawrence A. Diaz Gainesville, FL

1980-81 Joe Cuellar*

Temple Terrace, FL

1981-82 Peter C. Demro Ocala, FL

1982-83 John C. King

Mission Statement United to Advance Health Care and Pharmacy Practice

Bartow, FL

1983-84 Michael W. Stamitoles Pensacola, FL

1984-85 George B. Browning Melbourne, FL

1985-86 Max A. Lemberger* St. Augustine, FL

1986-87 Robert Fishman Hollywood, FL

1987-88 Kenneth R. Norfleet Brooksville, FL

1988-89 Allen Nichol

Coral Gables, FL

1989-90 Red N. Camp Titusville, FL

1990-91 Ed L. Hamilton Lake Alfred, FL

1991-92 Betty J. Harris

Delray Beach, FL

1992-93 S. Mark Hobbs

Merritt Island, FL

1993-94 M. Peter Pevonka Gainesville, FL

1994-95 Allen David Knee Sunrise, FL

1995-96 James Koivisto Jacksonville, FL

1996-97 James Powers

2009-10 Karen Whalen

1997-98 Paul Ackerman

2010-11

1998-99 Rebecca R. Poston

2011-12

1999-2000 Eric M. Alvarez

2012-13

2000-01 Robert Wilson

2013-14

2001-02 Joy Marcus

North Miami, FL

2014-15 Suzanne Kelley Pensacola, FL

2002-03 Tom Cuomo

2015-16 Tim Rogers

2003-04 Theresa W. Tolle

2016-17 Scott Tomerlin

2004-05 Glenn Boyles

2017-18 Suzy Wise

Tallahassee, FL

Palm Beach Gardens, FL Winter Springs, FL Miami, FL

Pensacola, FL

Cape Coral, FL Grant, FL

Wellington, FL

2005-06 Kathy Petsos

Cape Canaveral, FL

2006-07 Lee Fallon

The Villages, FL

2007-08 Don Bergemann

Tarpon Springs, FL

2008-09 Norman Tomaka Melbourne, FL

Gainesville, FL

Humberto Martinez Miami, FL Bob Parrado Tampa, FL Goar Alvarez Cooper City, FL Terry Gubbins Riverview, FL

Newberry, FL Rockledge, FL Orlando, FL

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FPA ORGANIZATIONAL CHART

FPA Member

House of Delegates

Board of Directors

President’s Committee of the Board of Directors

ACPP

(Advisory Council on Pharmacy Practice)

Invited and Affiliated Organizations

EVP and CEO

AD Hoc Committees

FPA Staff Governmental Affairs Committee

Budget and Finance Committee

Standing Councils Public Affairs Professional Affairs Organizational Affairs Educational Affairs Membership Affairs Student Affairs

JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

Code of Ethics for Pharmacists PREAMBLE Pharmacists are health professionals who assist individuals in making the best use of medications. This Code, prepared and supported by pharmacists, is intended to state publicly the principles that form the fundamental basis of the roles and responsibilities of pharmacists. These principles, based on moral obligations and virtues, are established to guide pharmacists in relationships with patients, health professionals and society. A pharmacist respects the covenantal relationship between the patient and pharmacist. Considering the patient-pharmacist relationship as a covenant means that a pharmacist has moral obligations in response to the gift of trust received from society. In return for this gift, a pharmacist promises to help individuals achieve optimum benefit from their medications, to be committed to their welfare, and to maintain their trust.

A pharmacist promotes the good of every patient in a caring, compassionate and confidential manner. A pharmacist places concern for the well-being of the patient at the center of professional practice. In doing

II.

so, a pharmacist considers needs stated by the patient as well as those defined by health science. A pharmacist is dedicated to protecting the dignity of the patient. With a caring attitude and a compassionate spirit, a pharmacist focuses on serving the patient in a private and confidential manner. III. A pharmacist respects the autonomy and dignity of each patient. A pharmacist promotes the right of self-determination and recognizes individual self-worth by encouraging patients to participate in decisions about their health. A pharmacist communicates with patients in terms that are understandable. In all cases, a pharmacist respects personal and cultural differences among patients. IV. A pharmacist acts with honesty and integrity in professional relationships. A pharmacist has a duty to tell the truth and to act with conviction of conscience. A pharmacist avoids discriminatory practices, behavior or work conditions that impair professional judgment, and actions that compromise dedication to the best interests of patients. V.

A pharmacist maintains professional competence. A pharmacist has a duty to maintain knowledge and abilities as new medications, devices and technologies become available and as health information advances.

VI. A pharmacist respects the values and abilities of colleagues and other health professionals. When appropriate, a pharmacist asks for the consultation of colleagues or other health professionals or refers the patient. A pharmacist acknowledges that colleagues and other health professionals may differ in the beliefs and values they apply to the care of the patient.

We Deliver Solutions for a Healthier Bottom Line • Group volume purchasing power • Aggressive wholesaler pricing programs • Successful rebate program - $42.7 million returned to members in 2017 • EPIC Pharmacy Network, Inc. (EPN) membership fee included at no cost – access to third-party contracts • Clinical services tools, including expert assistance from our in-house pharmacist and access to custom PrescribeWellness offerings and EQuIPPTM • – free third-party claims reconciliation program and automated reimbursements below cost system • – Web-based solution for pharmacy regulatory and compliance management

PUT THE POWER OF A NETWORK BEHIND YOU

800-965-EPIC | EPICRX.COM 14

FLORIDA PHARMACY TODAY

VII. A pharmacist serves individual, community and societal needs. The primary obligation of a pharmacist is to individual patients. However, the obligations of a pharmacist may at times extend beyond the individual to the community and society. In these situations, the pharmacist recognizes the responsibilities that accompany these obligations and acts accordingly. VIII. A pharmacist seeks justice in the distribution of health resources. When health resources are allocated, a pharmacist is fair and equitable, balancing the needs of patients and society. Approved by: FPA House of Delegates and APhA Active and Life members October 1994.

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

UNIT ASSOCIATIONS REGIONAL MAP History of The Florida Pharmacy Association Established in 1887, The Florida Pharmacy Association (FPA) has been serving the pharmacists and pharmacy technicians of the state of Florida for over a century. FPA encompasses all aspects of pharmacy (hospital, independent and chain, nursing home, consulting home health care, managed care, etc.) and strives to stay abreast of the needs of a rapidly changing pharmacy practice community.

The Florida Pharmacy Association Needs Your Involvement. The Florida Pharmacy Association is currently filling positions for its 2018-2019 Standing Councils. If you are interested in serving as a member of an FPA Council, please fill out the form below.

Florida Pharmacy Standing Councils The Florida Pharmacy Association (FPA) has created six standing councils to assist in the development of Association policy and activities as well as to better serve the FPA membership. The councils have also been formed to provide members with a mechanism for representation. FPA's councils include Educational Affairs, Organizational Affairs, Professional Affairs, Public Affairs, Membership Council and Student Affairs Council. EDUCATIONAL AFFAIRS: The Educational Affairs Council proposes policy and programs designed to provide quality continuing education to the pharmacists and technicians of Florida. ORGANIZATIONAL AFFAIRS: The Organizational Affairs Council considers issues pertaining to the structure, function and development of the Association, including membership issues. PROFESSIONAL AFFAIRS: The Professional Affairs Council monitors issues of interest to the profession of pharmacy, including legislative changes and Florida Board of Pharmacy law changes, and interfaces with other professions as they relate to pharmacy. PUBLIC AFFAIRS: The Public Affairs Council disseminates material relating to the practice of pharmacy to the public, in order to enhance the image of the profession of pharmacy.

MEMBERSHIP COUNCIL: The council was formed to facilitate the Association’s membership recruitment and retention programs, as well as to oversee the activities of the #1 Club or any other matters referred to it for consideration. STUDENT AFFAIRS : The Student Affairs Council promotes and encourages student involvement in the FPA, and serves as a liaison between the FPA and Florida Colleges of Pharmacy. Council meetings are held three times a year in central Florida. Meetings are held on Saturdays from 10 a.m. to 3 p.m. allowing members to drive in and out the same day. As a member of a Council, the FPA will assist in your travel expenses. Council members will serve two-year terms.

Please complete the form today and return by April 1, 2019, to: Florida Pharmacy Association, Attn: Christopher Heil, 610 N. Adams St., Tallahassee, FL 32301 or FAX (850) 561-6758. YES, I am interested in serving on an FPA Council. The council I am most interested in is:  Educational Affairs  Organizational Affairs  Professional Affairs  Public Affairs  Membership Council  Student Affairs Council

NAME ADDRESS CITY

STATE

HOME PHONE

WORK PHONE

ZIP

JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

The Officers and Executive Committee of the Florida Pharmacy Association cordially invite you to join the

#1 CLUB This exclusive organization recognizes outstanding

contributors to membership development within the Florida Pharmacy Association. The Florida Pharmacy Association’s (FPA) prestigious #1 Club, established in 1985, recognizes those members who demonstrate extraordinary commitment to increasing membership in the FPA. You are challenged to become one of the select few who achieve #1 Club membership. Eligibility requirements and benefits of membership are described below. Each new member sponsored brings you a step closer to becoming a part of this elite organization, and increases the strength and influence of the entire pharmacy profession.

Eligibility Requirements:

Membership in the #1 Club may be attained by sponsoring 10 new active regular members to the FPA and participation in one retention program. The 10 recruited member records shall be current and active just prior to the annual meeting of the FPA, as determined by FPA staff. Active membership in the #1 Club must be maintained by sponsoring three (3) new regular members to the FPA each year following that of your installation and participation in two membership retention programs per year, or preparation of a Journal article on the advantages of membership. Students can also participate in the #1 Club recruitment program and will be eligible to receive a #1 Club T-shirt upon recruiting 3 new pharmacist members. These recruited pharmacist members can be included in the #1 Club red jacket designation should the number of member pharmacists recruited get to the 10 member level.”

Benefits of Membership:

1. One complimentary registration for you to the FPA Annual Meeting and Convention EACH YEAR that active membership in the #1 Club is maintained. 2. Engraved membership plaque to be awarded at the FPA Annual Meeting and Convention when installed into the #1 Club. 3. Distinctive red jacket with #1 Club crest indicating membership in the #1 Club.

Florida Pharmacy Association Retention Programs:

1. Call 20 members who have not renewed their membership dues. 2. Coordinate bringing a group of local pharmacists to Florida Pharmacy Association’s Legislative Days. 3. Serve on the Membership Council to develop new retention programs, discuss membership issues or to develop membership satisfaction surveys. 4. Call and welcome 20 new members who were not sponsored in the #1 Club program. 5. Use the online “Refer a Friend” tool to invite 10 pharmacists to become members. 6. Visit a graduating class with an invitation to FPA membership. For more information on the #1 Club, contact: Chris Heil, 610 North Adams Street Tallahassee, FL 32301 850-222-2400 16

FLORIDA PHARMACY TODAY

#1 CLUB MEMBERS Carmen Aceves Paul Ackerman Ann Marie Aldrich Eric Alvarez Goar Alvarez Eli Berkofsky Glenn Boyles Joseph Burghardt Leonard “Red” Camp Chris Christopolous Tom Cuomo Ana De La Huerta Paul Delisser*** Art Diaz Marcus Dodd-O Jackie Donovan Leo “Lee” Fallon*** Raul Gallo Mayra Gonzalez-Abreu Terry Gubbins*** Ed Hamilton Betty Harris Carl “Fritz” Hayes S. Mark Hobbs Thomas Isbon Michael Jackson*** Alan Katz Suzanne Kelley David Laven Georgia Lehoczky Joy J. Marcus Humberto Martinez David Mackarey*** Robert Miller Hugh Morrow Tian Merren Owens*** Allen Nichol Mary Kay Owens Bob Parrado Kathy Petsos Rebecca Poston James Powers Michael Stamitoles Theresa Tolle Norman P. Tomaka Scott Tomerlin*** Alton Tower Robert H. Wilson

***Denotes active #1 Club Members who have recruited three new regular pharmacist members.

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FPA Officer and Director Nominations Although we have just finished the election for a President-Elect and Directors for the even-numbered regions who were installed at the 2018 annual meeting, it is time to start thinking about nominees for the 2019 election, since the nomination deadline is September 1 of this year (9/1/18). As the form below indicates, this year we will need candidates for President-Elect, Treasurer and Directors for the odd-numbered regions. Please note that you may nominate yourself. CALL FOR FPA OFFICER AND DIRECTOR NOMINATIONS for 2019 Elections The FPA bylaws specify that any subdivision or any member in good standing may nominate one person for the office of President-Elect and one person for the office of Treasurer. A President-Elect shall be elected every year and shall assume the duties of the President on the last day of the annual meeting of the year following election as President-Elect. The Treasurer shall serve a two-year term and may succeed to one consecutive term of office in that capacity. Nominees must be Florida registered pharmacists in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Nominees for President-Elect should have a good understanding of how the Association functions and should be current on the issues impacting pharmacy. Nominees for Treasurer should have good analytical skills and experience and ability in financial management and budget preparation. There are nine regional Board Directors who shall serve two-year terms. A nominee must be a Florida registered pharmacist in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Additionally, each Board Director must be a member of at least one the FPA Unit Associations within their region. Board Directorsâ&#x20AC;&#x2122; terms are staggered such that even-numbered regions shall be elected in even-numbered years and odd-numbered regions shall be elected in odd-numbered years. All newly elected Board of Directors Regional Directors shall take office on the last day of the annual meeting, and shall continue in office until the last day of annual meeting of the second ensuing year.

FPA CANDIDATE NOMINATION FORM I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION: NAME: ADDRESS:

FOR THE FOLLOWING OFFICE:

(Nomination deadline: September 1, 2018)

q President-Elect q Treasurer q Region 1 q Region 3 q Region 5 q Region 7 q Region 9 NOMINATED BY: NAME: DATE SUBMITTED: SIGNATURE:

MAIL NOMINATIONS TO: Election Nominations, Florida Pharmacy Association, 610 N. Adams St., Tallahassee, FL 32301 (850) 222-2400 FAX (850) 561-6758 DEADLINE FOR NOMINATIONS IS SEPTEMBER 1, 2018

JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FPA Constitution Article I Name The association shall be called the Florida Pharmacy Association, hereinafter called the Association. Article II Object a. The Association shall be to unite all persons interested in the profession of pharmacy in the State of Florida for the following purposes: b. To support and encourage higher standards of pharmaceutical education at all levels of the profession in order to attract qualified personnel into the profession of pharmacy. c. To encourage and maintain relations with all healthcare professions and governmental bodies and agencies to enhance the overall quality of healthcare. d. To ensure pharmacy is practiced by properly qualified pharmacists, to protect the welfare of the public. e. To serve, represent, and assist the Florida pharmacists to advance the profession and practice of pharmacy. Article III Membership The Association shall have six types of membership: Regular, Associate, Student, Honorary, Pharmacy Technician, and Lifetime. Section 1 - Regular Members. Regular members shall be those persons who otherwise qualify as members in good standing and who are licensed pharmacists, entitled to practice pharmacy. Section 2 - Associate Members. Associate members shall be those persons who otherwise qualify as members in good standing, and are interested in pharmacy or are associated with a business or profession related to the pharmaceutical profession. Associate members shall submit an application for membership and shall comply with such requirements as may be established by the Association and its Bylaws. Section 3 - Student Members. Student members shall be those persons who otherwise qualify as members in good standing and are students in good standing, matriculated in a college or school of pharmacy or a Board of Pharmacy approved school or technician training program. Section 4 - Honorary Members. The Association may elect to honorary membership any person interested in pharmacy or its related sciences, at any annual meeting or special 18

FLORIDA PHARMACY TODAY

meeting of the Association called for such purpose. Section 5 - Pharmacy Technicians. Pharmacy Technician members shall be those persons who assist licensed professional pharmacists in performing their professional duties as defined in F.S. 465. Pharmacy Technician members shall submit an application for membership and shall comply with such requirements as may be established by the association and its bylaws. Section 6 - Lifetime Members. Current Association Regular members receiving the Florida Board of Pharmacy 50year certificate shall receive Lifetime membership in the Association. Article IV Officers The officers of the Association shall be the President, the President-Elect, the Treasurer, the Executive Vice President, the Board of Directors Chairman, Speaker of the House of Delegates and Vice Speaker of the House of Delegates. Section 1 - President. The President shall preside at all meetings of the Association and shall perform all other duties that may be incident to that office. Section 2 - President-Elect. The President-Elect shall perform all duties of the President in the absence or inability of the President to serve. The President-Elect shall be the official representative of the Association on the Board of Directors of the House of Delegates. Section 3 - Treasurer. The Treasurer shall perform all duties incident to the office of Treasurer. Section 4 - Executive Vice President. The Executive Vice President shall be the executive officer of the Association and shall conduct and administer the affairs of the Association in accordance with the Constitution and Bylaws and subject to the policies and directives of the Board of Directors. Section 5 - Board of Directors Chairman. The Board of Directors Chairman shall be the Immediate Past President of the Association. This chairman shall chair all meetings of the Board of Directors and shall arrange the meeting and expedite all business to be transacted by this Board of Directors. The Chairman may select another member of the Board of Directors to serve in his/her absence or, if none is selected, the President may chair a preliminary meeting to select a Board of Directors member to chair that meeting.

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. Section 6 - Speaker of the House of Delegates. The Speaker of the House of Delegates shall be the person elected by the House of Delegates to serve as the Speaker. The Speaker shall be the official representative of the House of Delegates on the Board of Directors. Section 7 – Vice Speaker of the House of Delegates. The Vice-Speaker shall be the person elected by the House of Delegates to serve as Vice Speaker. The Vice-Speaker shall be installed as the Speaker in one year. Section 8 - Qualification of Officers. No person shall be elected to any office in the Association unless such person is a member in good standing. Section 9 - Inability to Serve. In the event of the death or inability of an officer to serve, the President will appoint a replacement with the approval of the Board of Directors to complete the term of the office, or until an election is held. Article V Board of Directors Section 1 - Membership. There shall be a Board of Directors of which the Immediate Past President of the Association shall be chairman. The Board of Directors will consist of the following 19 members: ■■

■■ ■■ ■■ ■■ ■■

Board of Directors shall, in their usual order of business, review the report of the President’s Committee and approve or correct actions the President’s Committee has taken on behalf of the Board of Directors. The Board of Directors shall perform such other duties as are normally incident to such a committee. Any member of a Florida Pharmacy Association Council or Committee is not authorized to speak on behalf of the Association, either verbally or in writing, without the approval of the Board of Directors. Section 3 - Meetings. The Board of Directors shall meet at least twice a year at such times that one of the meetings must occur no more than eight months and no less than one month prior to the regular annual meeting of the Association. A meeting of the Board of Directors may be called by the chairman or by petition of one-fourth of its members at other times as Association business may demand. A quorum of the members of the Board of Directors, as defined in the Bylaws, must be present in order to transact any business.

The elected officers of the Association ●● Immediate Past-President, as chair ●● President ●● President-elect ●● Treasurer ●● Speaker of the House ●● Vice Speaker of the House of Delegates The Executive Vice-President of the Association, as secretary The President of FSHP Nine (9) elected directors who will serve staggered terms One (1) elected student director One (1) elected technician

Section 2 - Duties. The Board of Directors is the only body that can establish and implement policy for the Association. The Board of Directors shall approve the Executive Vice President, approve his salary and other terms of his appointment; the term of office; prescribe his duties and direct his activities where such duties and activities are not specifically provided in the Constitution or Bylaws. The Board of Directors shall be responsible for arranging and expediting business during meetings of the Association. The Board of Directors shall expend the funds of the Association for such matters and things as, in the judgment of the Board of Directors, shall be for the betterment of pharmacy in the State of Florida and of value to the members of the Association, the profession of pharmacy, and the health and welfare of the citizens of the State of Florida. The Board of Directors shall audit charges against the Association. The JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. All meetings of the Board of Directors shall be open to any Regular Member and the membership shall be informed of the meeting by the Executive Vice President in advance, when time permits; however, all members of this Board of Directors must be notified. Section 4 - Voting. Only members of the Board of Directors shall be entitled to vote at a meeting of the Board of Directors. Any member of the Board of Directors may designate another member of the Florida Pharmacy Association to cast his vote by proxy as defined in the Bylaws. Section 5 - Qualifications to Board of Directors. No person shall be appointed to the Board of Directors unless such person is a member in good standing. Article VI Meetings Section 1 - Regular Meetings. There shall be an annual meeting of the Association at such time and place as the Board of Directors shall direct. Section 2 - Special Meetings. Special meetings of the Association may be held from time to time as the business of the Association may require, upon written request of fifty (50) Regular Members of the Association. In the event of such a special meeting, the Executive Vice President shall

A Pharmacist And A Lawyer Licensure Disciplinary Proceedings Insurance Company/PBM Audits and Appeals Purchase & Sales of Pharmacies Regulatory Compliance Consultants Business Operations Consultants KAHAN & ASSOCIATES, PLLC

Pharmacist Attorney Brian A. Kahan, R.Ph., J.D. Licensed Florida Pharmacist and Attorney

STATEWIDE REPRESENTATION 561-392-9000 bkahan@kahanlaw.com 7000 West Palmetto Park Road, Suite 210 Boca Raton, FL 33433 The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.

FLORIDA PHARMACY TODAY

mail written notice to each voting member no less than twenty-five (25) days prior to the date of such meeting. The notice shall state the time and place of such meeting and all the matters to be brought before the Association at such special meeting unless deemed to be of an emergency nature by the Board of Directors. Section 3 - Voting. At any regular or special meeting of the Association, all members in good standing in this Association shall be entitled to vote, except for Honorary Members. Article VII House of Delegates There shall be established a House of Delegates as defined in the Bylaws of the Association. Article VIII Presidentâ&#x20AC;&#x2122;s Committee There shall be established a Presidentâ&#x20AC;&#x2122;s Committee as defined in the Bylaws of the Association. Article IX The Florida Pharmacy Foundation There shall be established a foundation as defined in the Bylaws of the Association. Article X Florida Pharmacy Today Corporation There shall be established a Florida Pharmacy Today Corporation as defined in the Bylaws of the Association. Article XI Bylaws The Association may establish such Bylaws, not in conflict with this Constitution, as may be deemed necessary to direct and control the affairs of the Association. Article XII Amendments This Constitution may be altered or amended provided that such proposal to alter or amend same shall be submitted to the Chair of the Organizational Affairs Council in writing. The proposed alteration or amendment to the Constitution shall be read at the annual meeting of the Association. Upon majority approval of the membership voting, the proposed amendment shall then be referred to the Board of Directors who shall cause the Executive Vice President to publish such proposed amendment in the Florida Pharmacy Today, which is placed in circulation at least thirty (30) days prior to the ballot being mailed to the membership. Upon the vote of three-fourths (3/4) of the voting members returning the ballot by the specified deadline, in favor of adoption of the amendment, it shall become a part of this Constitution. Revised 02/2006, 02/2008, 2/2011, 2/2016, 2/2017

Personal Umbrella

Tomorrow. Imagine That.

phmic.com

All products may not be available in all states and territories.

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FLORIDA PHARMACY ASSOCIATION BYLAWS Article I Name & Location Section 1 - Name. The name of the Association shall be the Florida Pharmacy Association, hereinafter referred to as the Association. Section 2 - Location. Offices for transaction of business of the Association shall be located at such places as the Board of Directors shall from time to time determine and direct. Article II Membership Section 1 - Qualifications. Any person may be admitted to membership of the Association, who shall qualify for membership pursuant to the Constitution and by making application to the Executive Vice President of the Association, together with the appropriate annual dues. Section 2 - Certificates. A suitable certificate showing the memberâ&#x20AC;&#x2122;s name, membership classification and a membership card showing the term for which membership fee has been paid shall be furnished to all members by the Executive Vice President. Article III Annual Membership Fee Section 1 - Due Date. The annual membership fee shall be an amount as hereinafter set forth and shall be due and payable on January 1 or July 1 of each calendar year in accord with the appropriate membership cycle. Section 2 - Dues Amount. A. The dues for Regular Members shall be determined by the Budget and Finance Committee and shall be approved by the Board of Directors. B. The dues for Regular Associate Members shall be the same as dues for Regular Members. C. The dues for Associate Pharmacy Technician Members shall be determined by the Budget and Finance Committee and shall be approved by the Board of Directors. D. The dues for Student Members shall be determined by the Budget and Finance Committee and shall be approved by the Board of Directors. E. The dues for Retired Pharmacists shall be one-half the dues for Regular Members.

FLORIDA PHARMACY TODAY

F. The dues for Joint Membership with a spouse paying the Regular Member rate shall be one-half the dues for Regular Members. G. The dues for New Practitioners following graduation from pharmacy school shall be one-half the dues fee for Regular Members for the first year out of school and the Regular Members rate the second year after graduation from pharmacy school. H. The dues for Honorary or Lifetime members shall be waived. Section 3 - Grace Period. Any member not paying their annual dues within ninety (90) days after the due date shall have their services discontinued until said annual dues are paid in full. During times of national military service, established members shall have no less than a six (6) month grace period upon return to civilian status to pay their annual dues. Such members shall retain all rights and privileges of membership during the service and grace periods. Section 4 - Joint Billing of Membership Fees. The Association shall bill jointly for the membership fee of the Association, as defined in these Bylaws, and for the membership fee of each affiliated county or local Association, hereinafter referred to as Unit Associations, if so requested. The membership fee for each Unit Association shall be determined by their own membership, and the amount collected shall be returned to the Unit Association. Section 5 - Budget Related Increases. The Association with the recommendation of the Budget and Finance Committee may increase the dues amount in any or all membership categories, as listed in Section 2, by an amount not to exceed 3% annually. Any dues increase greater than 3% must be approved by the House of Delegates. Article IV Subdivisions Section 1 - Unit Associations. The term Unit Associations shall be the term used to describe all local or county associations. The Unit Associations can best represent the local pharmacists in items of local interest and concern but should also be the means of communication with pharmacy, state and nationwide. Any organized group of pharmacists within Florida may request to be designated an affiliated unit association of the Florida Pharmacy Association. Any such request must be made in writing and must be accompanied by the following: 1) a copy of the organizationâ&#x20AC;&#x2122;s current constitution and

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. bylaws 2) a list of the names, addresses and phone numbers of the organization’s officers 3) a list of the organization’s members of which no fewer than 10 must be FPA members 4) a written statement signed by the officers of the association, which documents the organization’s support for the FPA Mission Statement and the organizations’ desire to participate fully and actively in the FPA House of Delegates. The Organizational Affairs Council shall certify in writing to the Board of Directors that the unit associations’ constitution and bylaws are consistent with the objectives and organizational characteristics of the Florida Pharmacy Association. Upon a majority vote by the Board of Directors the unit association may become affiliated. The Board of Directors shall establish geographical areas comprised of approximately equal numbers of pharmacists within the State to be termed Regions, and will periodically re-evaluate the number and size of these Regions. Each region will have an elected regional director that will serve on the Board of Directors of the Association. Section 2 - Advisory Council on Pharmacy Practice. There shall be an Advisory Council on Pharmacy Practice which should educate the FPA Board of Directors on emerging issues impacting pharmacy through written communications, formal presentations and discussion of these issues. The Advisory Council on Pharmacy Practice should meet with the FPA Board of Directors at some specified point in time in conjunction with a planned weekend gathering of the FPA Councils and Committees, as well as the FPA Board of Directors, so that presentation of issues (and any recommendations for action pertaining thereto) can be presented to the FPA Board of Directors and other interested FPA Councils and Committees. Section 3 - Foundation. There shall be a foundation, the purpose and functioning of which shall be as described in the foundation’s constitution and bylaws. The Chief Executive Officer of the foundation shall report on the foundation’s activities at each meeting of the Board of Directors. Section 4 - Florida Pharmacy Today Corporation. There shall be a Florida Pharmacy Today Corporation, the purpose and functioning of which shall be as described in the Florida Pharmacy Today Corporation constitution and bylaws. The Chairperson of the Florida Pharmacy Today Corporation shall report on the Journal Board’s activities at each meeting of the Board of Directors. Article V House of Delegates

recognized by the Association as being entitled to representation in the House of Delegates shall be entitled to two (2) delegates. Each affiliated Unit Association shall be entitled to these two (2) delegates plus one (1) additional delegate for each fifty (50) members or major fraction thereof, provided that no such association may be entitled to more than seven (7) delegates. The officers of each individual organization shall make a report to the Speaker of the House of Delegates once each year in order to verify the identity and address of the officers and number of members in each organization. An amended report may be made up to thirty (30) days prior to the Annual Conference if a change in membership will change the number of delegates to which the organization is entitled. Section 3 - Delegates. The name and address of each official delegate shall be sent to the Speaker of the House of Delegates by the officers of the organization he represents. Each official delegate shall be a member in good standing of the Florida Pharmacy Association. Each delegate shall maintain their membership in the Association during their term of service as a delegate. The usual term of service of all delegates shall coincide with the usual term of office of the President of the Association. Section 4 - Meetings. The House of Delegates shall meet during a meeting of the Association in order to act upon resolutions presented to the Association. Section 5 - Rules of the House of Delegates. The House of Delegates shall adopt rules and regulations for the functioning of the House of Delegates which shall not conflict with the Constitution and Bylaws of the Association. Section 6 - Association Policy. The official policy positions of the Florida Pharmacy Association shall be determined by the House of Delegates. Interim policy decisions may be made by the Board of Directors of the Association or the President’s Committee, subject to review and approval at the next meeting of the House of Delegates. Section 7 – Who May Submit a Resolution. All resolutions emanating from an individual member or group of members must conform to the resolutions format prescribed by the House of Delegates and bear the name(s) of the sponsor(s) at least one (1) of whom must be present at the House of Delegates session to introduce their resolution by reading. Article VI Quorum & Proxy Vote

Section 1 - Establishment of Rules. The Association shall recognize, through its Board of Directors, all organizations entitled to representation in the House of Delegates.

Section 1 - Annual and Special Meetings of the Association. Fifty (50) voting members shall constitute a quorum for the transaction of business at any annual or special meeting of the Association.

Section 2 - Apportionment. Each organization officially

Section 2 - Board of Directors Meetings. Attendance by more JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. than 50% of the voting members of the Board of Directors shall constitute a quorum for the transaction of business at any meeting of the Board of Directors. Section 3 - Proxy Vote. Any member of the Board of Directors who is unable to attend a meeting of said Board of Directors may, by giving written notice to the chairman of the Board of Directors, specify a proxy to cast his vote at the meeting. Regional Directors must designate as proxy an FPA member in good standing from the same region. Organization directors must designate another FPA member from the same organization. The Chairman must inform the membership present of all written notices of proxy he has received as the first order of business. Representation by proxy may not be counted to make a quorum. Article VII Committees/Councils Section 1 - Appointment of Committees/Councils. The President shall appoint committees/councils as listed in this article unless otherwise provided and such other committees/ councils as the President shall deem necessary. The President shall appoint only members in good standing as members of all committees/councils and shall serve as an ex-officio member of each committee/council he appoints. The chairs of the standing councils should file reports with the President and President-elect. Any recommendations contained in those reports must include an indication of how many committee members were present. Any member of a Florida Pharmacy Association Council or Committee is not authorized to speak on behalf of the Association, either verbally or in writing without the approval of the Board of Directors. Section 2 - President’s Committee. There shall be a President’s Committee composed of the President, as Chairman, the President-Elect, the Treasurer, the Immediate Past President, the Speaker of the House of Delegates, Vice Speaker of the House of Delegates and the Executive Vice President. This committee shall be charged with making the decisions required to implement the actions of the Board of Directors. The President’s Committee may take actions on behalf of the Association and may make interim decisions between meetings of the Board of Directors, subject to review and approval by the Board of Directors. The President will report to the Board of Directors, at its regular meeting, the actions taken on their behalf, for their approval. Section 3 - Budget and Finance Committee. The President’s Committee shall appoint a Budget and Finance Committee composed of the: 1. Treasurer who shall serve as Chair 2. Immediate Past Treasurer, who shall serve as Vice Chair 3. President of the Association 4. Immediate Past President 5. Speaker of the House of Delegates 24

FLORIDA PHARMACY TODAY

6. Two (2) members selected by the President as At-Large members who shall serve staggered terms of two (2) years and may be selected for reappointment; and 7. President-Elect 8. Executive Vice President 9. Vice Speaker of the House of Delegates 10. All members of the Budget & Finance Committee shall be voting members, except for the position of Immediate Past Treasurer. The Budget and Finance Committee shall be responsible for the: 1. investment policy of the Association 2. preparation of an annual budget; and 3. development of reimbursement policies for travel and per diem expenses of representatives of the Association The Board of Directors shall ratify all decisions of the Budget and Finance Committee; however, the Executive Vice President may obtain approval of the President’s Committee to implement decisions of the Budget and Finance Committee in the interim between meetings of the Board of Directors. The members of the Budget & Finance Committee and the President’s Committee will be indemnified for all investment decisions made within the parameters of the financial guidelines approved by the Board of Directors. Section 4 –Governmental Affairs Committee. A Governmental Affairs Committee shall be formed to consider any matters or issues pertaining to rules and regulations affecting the profession of pharmacy, or any other matters referred to it for consideration. This committee shall meet at least once a year or more often as the legislative environment mandates. The membership of the Governmental Affairs Committee should consist of the following: Chair, appointed by the President 1. The elected officers of the Association 2. The Executive Vice President of the Association, as secretary 3. FPA’s governmental Affairs Advisor/Lobbyist, as a non-voting member 4. At-large members (not to exceed 5), appointed by the President including at least one student. 5. Past Chair 6. Political Committee Chair 7. FSHP Liaison Section 5 - Standing Councils. A. Public Affairs. A Public Affairs Council shall be formed to consider matters or issues inherent in or arising from the interface of the profession with the public, or any other matters referred to it for consideration. B. Professional Affairs. A Professional Affairs Council shall be formed to consider matters or issues of interest to the pharmacy profession and arising from or inherent in the interface of the pharmacy profession with other professions,

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. or any other matters referred to it for consideration. C. Organizational Affairs. An Organizational Affairs Council shall be formed to consider matters and issues pertaining to the structure, function and development of the Association, or any other matters referred to it for consideration. D. Educational Affairs. An Educational Affairs Council shall be formed to consider any matters or issues pertaining to the pharmacy education, or any other matters referred to it for consideration. E. Advisory Council on Pharmacy Practice. An Advisory Council on Pharmacy Practice shall be formed and should educate the FPA Board of Directors on emerging issues impacting pharmacy through written communications, formal presentations and discussion of these issues. F. Membership Council. A Membership Council shall be formed to facilitate the Association’s membership recruitment and retention programs as well as to oversee the activities of the #1 Club or any other matters referred to it for consideration. G. Student Affairs Council. A student Affairs Council shall be formed to promote and encourage student involvement in the FPA, and to serve as a liaison between the FPA and Florida Colleges of Pharmacy. Section 6 - Council Membership. A. With the exception of the Advisory Council on Pharmacy Practice and the Student Affairs Council, standing councils shall be composed of seven (7) members, one of shall be the chairman and one shall be a Pharmacy Technician. The term of office for each council member shall be for two (2) years. The terms of membership shall be staggered so that at least three (3) members will be appointed each year. In addition to the above, there will be no more than three (3) invited Student representatives from Florida schools/colleges of Pharmacy for a one year term. The chairman, members and invited Student representative shall be selected by the President. B. The Advisory Council on Pharmacy Practice shall consist of, but not limited to, the following: 1. The President’s Committee of the FPA Board of Directors consisting of the President-elect (as Chair of the Advisory Council on Pharmacy Practice), President, Immediate Past-President, Treasurer, Speaker of the House of Delegates, Vice-Speaker of the House of Delegates, Executive Vice-President of the Association (as Secretary of the Advisory Council on Pharmacy Practice); 2. The Deans of Florida’s Colleges of Pharmacy or their designees; 3. The ASP Chapter Presidents from Florida’s Colleges of Pharmacy or their designees; 4. An FPA member representing each a community, institutional, and a non-traditional pharmacy practice area;

5. An invited representative of the Florida Chapter of the American Society of Consultant Pharmacists; 6. An invited representative of any independent pharmacist organization in Florida; 7. An invited representative of any pharmacy technician organization in Florida; 8. The President of the Florida Society of Health-System Pharmacists; and 9. Depending on the pharmacy issues under consideration, the Advisory Council’s Chair may invite additional representatives whose expertise in other areas of pharmacy practice, not otherwise noted above, is deemed of value to the discussions, with such invitations based upon the budgetary constraints of the Florida Pharmacy Association. C. The Student Affairs Council shall be composed of the following: 1. Two (2) students from each Florida College of Pharmacy (to include the student chair). 2. Three (3) pharmacists (to include the pharmacist cochair). 3. The term of office for each council member shall be for two (2) years. 4. The terms of membership shall be staggered so that at least one student from each school is appointed each year. 5. P4 students serving on the council would be encouraged to serve as a pharmacist on the council for the next year. 6. The chairman, co-chair, and council members shall be selected by the FPA President. Article VIII Delegates Section 1 - Appointment. The President may appoint such delegates to commercial bodies, medical societies, state associations or like gatherings as he may deem necessary and shall appoint delegates and alternates to attend the annual meeting of the American Pharmacists Association as well as delegates and alternates to the annual meeting of the National Community Pharmacists Association. The priority of these appointments by the President of the aforementioned delegates shall be as follows: 1. The current seated President and President-elect 2. Members of the President’s Committee 3. Members of the Board of Directors, and 4. Members of any Standing Council Section 2 - Expenses. The actual expenses incurred for transportation, lodging and meals by the President, the President-Elect and the Executive Vice President while attending the annual meeting of the American Pharmacists Association and National Community Pharmacists Association shall be paid by the Association upon presentation of proper itemized statements of expenses to the Executive Vice President and approval by the Board of Directors. All money advanced to any delegates to these meetings must JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. be accounted for by an itemized statement or returned to the general fund of the Association. The President and PresidentElect of the Florida Pharmacy Association, who are in office on the first day of January shall be the proper officers to attend the annual meeting of the APhA which falls within that year. Section 3 - Reports of Meetings. Officers attending said meetings shall make a full report of the meetings of the national bodies to this Association in person or by written report filed with the Executive Vice President to be published in the Journal. Article IX Rules of Order Robertâ&#x20AC;&#x2122;s Rules of Order shall be the authority on all points of order in the conduct of meetings of the Association. These Bylaws shall not be suspended without the consent of twothirds of the members present. Article X Amendments to Bylaws Amendments to these Bylaws shall be approved by the Board of Directors and proposed by them to the House of Delegates and approved by a two-thirds vote of those voting members present at a regular meeting or special meeting called for that purpose; provided, however, that thirty (30) days notice of that meeting shall be given by the House of Delegates in a manner approved by the Board of Directors. Article XI Publishing of Proceedings Section 1 - What to be Published. The proceedings of the Association, the roll of officers, committees, and members shall be published annually under the supervision of the Executive Vice President and the Board of Directors and a copy of the proceedings sent to each member of the Association not in arrears for membership fees.

Article XIII Nominations & Election Section 1 - Procedure for Nomination. A Nominating Committee will be appointed by the President by September 1st of each year. The committee will consist of the immediate Past Chairman of the Board of Directors, who will serve as Chairman, and a representative from each FPA standing council. No member serving on the committee shall be eligible to run for office. The committee will establish guidelines. Subdivisions or any FPA member in good standing may nominate one person for the office of President-Elect and one person for the office of Treasurer and one person for the office of Regional Director and one person for the office of Student Director and one person for the office of Technician Director. The Treasurer shall serve a two year term and may succeed to one consecutive term of office in that capacity. With the exception of the Student Director and Technician Director, a nominee must be a Florida licensed pharmacist. The Student Director must be a licensed Florida Pharmacy Intern. The Technician Director must be a registered Florida Pharmacy Technician. All nominees must be in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. The election process will be conducted by mail or electronic balloting. A Board of Canvassers composed of three (3) Past Presidents of the Florida Pharmacy Association appointed by the President, together with the Executive Vice President, shall tally the ballots. Balloting will be according to the following time schedule. Nominations shall be received at the Association headquarters not later than September 1st of each year together with a biographical sketch and a picture.

Article XII Expulsion or Removal of Members or Officers

Section 2 - Procedures for Election. With the exception of Student Director, the Executive Vice President of the Association shall determine every active member of the Association who, as defined in the Constitution, is qualified to vote by November 30, and shall issue to every active voting member a ballot which will contain the names of the nominees for President-Elect, Treasurer, Regional Directors, and Technician Director together with a biographical sketch and a picture, no later than January 1. The ballot for the position of Student Director shall be issued to every active Florida College of Pharmacy student FPA voting member.

Any member may be expelled from membership or removed from office for conduct which adversely affects the pharmacy profession the Association or the professional standing of a colleague, or for violating the Constitution or Bylaws. Any officer may be removed from office for non-residence, inability or unwillingness to perform his duties of office. No person shall be expelled or removed except by a two-thirds vote of all members of the Board of Directors present at a regular meeting or a special meeting called for such purpose and after he shall be given an opportunity to be heard in his own defense.

A. The qualified membership shall submit an electronic ballot or mark, seal and mail a paper ballot to the address specified on the ballot by January 31. B. With the exception of the Student Director, by the end of February the Board of Canvassers shall open and tally the ballots. The nominees receiving the majority of the votes shall be declared elected. If no single nominee shall receive a majority of the votes cast for the office, a run-off election shall be held between the nominees receiving the two highest

Section 2 - When Published. The Publication of the Proceedings shall be made and copies thereof mailed to members within two months after the close of the annual meeting.

FLORIDA PHARMACY TODAY

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. number of votes for each office in the following manner. 1. A second ballot shall be prepared containing the names of the nominees receiving the two highest number of votes for each office affected, together with biographical sketch and a picture. The Executive Vice President shall issue these ballots to every active member of the Association who is qualified to vote, at least thirty (30) days in advance of the annual meeting. 2. The active qualified membership shall submit an electronic ballot or mark, seal and mail an approved paper ballot to the address specified on the ballot by seven (7) days prior to the annual meeting. 3. The ballots cast in the run-off election shall be tallied no later than the close of the first general session of the annual meeting by the Board of Canvassers. The nominee receiving the majority of votes shall be declared elected. 4. If a tie vote should occur in the run-off election, a general election will be held at the last general session of the annual meeting with a majority vote deciding the winner. C. For the position of Student Director by the end of February, the Board of Canvassers shall tally the ballots submitted by students from each Florida College of Pharmacy. Each College of Pharmacy will have one collective vote for the Student Director as determined by majority vote from each respective school. In the event a nominee does not receive the majority of votes, the Student Affairs Council will make a recommendation to the FPA President to cast the tie-breaking vote after the ballots were counted. Section 3 - Elections of Board of Directors Regional Directors. Nine Board of Directors shall be elected according to regional requirements and shall serve a two-year staggered term. A Nominee must be a Florida licensed pharmacist in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. In the event that the Board of Directors Regional Director cannot fulfill the duties of the office, the President will appoint a replacement with the approval of the Board of Directors to complete the Director’s term of office or until an election is held. Elections for regional directors shall be held such that directors representing even numbered regions shall be elected in even number years, and directors representing odd numbered regions shall be elected in odd number years. All newly elected Board of Directors Regional Directors shall take office on the last day of the annual meeting and shall continue in office until the last day of the annual meeting of the second ensuing year. Section 4 - Elections of Student Director. The Student Director shall be elected according to Article VIII Section 2 Subsection C requirements and shall serve a two-year term. A Nominee must be a Florida licensed pharmacy intern in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Section 5 - Elections of Technician Director. The Technician Director shall be elected according to Article VIII Section 2 Subsection B requirements and shall serve a two-year term.

A Nominee must be a Florida Licensed Pharmacy Technician in good standing with the Florida Pharmacy Association and the Florida Board of Pharmacy. Section 6 - Assumption of Office. All newly elected officers shall take office on the last day of the annual meeting, and shall continue in office until the last day of the annual meeting of the next ensuing year. All newly elected Board of Directors Regional Directors shall take office on the last day of the annual meeting, and shall continue in office until the last day of annual meeting of the second ensuing year. The President-Elect shall assume the duties of the President on the last day of the annual meeting of the year following his election as President-Elect. Article XIV Duties of Officers. Section 1. President. The President of the Florida Pharmacy Association: I. Sets goals, themes and topics to be addressed by the councils/committees and chairs. II. Announces appointments of council/committee members and chairs for standing councils/committees. III. Chairs a leadership retreat, if funding allows, with incoming council/committee chairs and leadership to serve as an introduction to the President’s theme and goals for the year. IV. Chairs the President’s Committee that reviews and decides on issues in between Board of Directors meetings V. Shall form and appoint members to ad-hoc committees, on an as needed basis, to address topics of concern to the profession. VI. Participate in the Budget and Finance Committee and appoints the one at-large member, in coordination with the President’s Committee. VII. May appoint delegates to represent the FPA and Florida Pharmacy to other state or national associations, governmental and/or other commercial bodies. VIII. Represents the FPA by attending appropriate pharmacyrelated events and activities. IX. Uses all forms of communication to relate issues and topics to FPA membership and stakeholders. This communication includes contributions to the Florida Pharmacy Today Journal, STAT newsletter, website, or other media as issues require. X. Appoints the Nominating Committee. XI. Appoints the Canvassing Committee. XII. Presides and Chairs the annual business meeting at the convention. XIII. Presides over and inducts the Board of Directors at the President’s breakfast. Section 2. President-Elect. The President-Elect of the Florida Pharmacy Association: I. Chairs the Advisory Council on Pharmacy Practice meeting. JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. II.

Substitutes for the President in the event the President is unable to participate in activities. III. Reviews and approves the slate of officers of the political action committee Board of Directors. IV. Considers selection of upcoming council/committee members and chairs for standing councils/committees. Section 3. Chairman of the Board. The Chairman of the Board of the Florida Pharmacy Association: I. Coordinates recommendations from Advisory Council on Pharmacy Practice. II. Chairs the Board of Directors meeting. III. Ensures the President-Elect reaches out to the chairs of FSHP L & R Committee and the FPA GAC and invites them to attend each meeting. Section 4. Treasurer. The Treasurer of the Florida Pharmacy Association: I. Will work with the Executive Vice President and President to develop an annual budget for presentation to the Budget and Finance Committee and/or President’s Committee; II. Will review the Association’s expenditures and receipts prior to each Board of Directors meeting; III. Has oversight authority of the Budget and Finance Committee and will provide written certification to the Board of Directors during each Board of Directors Meeting; IV. Will as immediate past treasurer, serve on the Nominating Committee as an Ex-Officio member to screen nominees for the position of Treasurer and President-Elect; V. Will make a written Annual Report to the membership and present an oral report at the Annual Business meeting and be prepared to respond to questions;

FLORIDA PHARMACY TODAY

Section 5. Speaker. Speaker of the House of Delegates of the Florida Pharmacy Association I. Will preside over the meetings of the House of Delegates II. Will ensure a quorum is established, call the meeting to order, maintain proper decorum, and proceed under Roberts Rules of Order III. Will be a delegate in case there is a tie breaker situation IV. Will be responsible for producing a report of the actions of the House of Delegates to the members of the Florida Pharmacy Association Section 6. Vice Speaker. Vice Speaker of the House of Delegates of the Florida Pharmacy Association I. Will assist the Speaker in the performance of the Speaker’s duties and/or perform such as specified by the House of Delegates. II. In the event of a vacancy in the position of Speaker of the House, or in the event the Speaker is unable to perform the duties of the office during a meeting of the House of Delegates, the Vice Speaker shall assume the duties of the Speaker. III. Will be the FPA liason to local affiliated units and conduct their meeting at the FPA Annual Meeting. IV. Will be elected during the FPA Annual Meeting by the House of Delegates Revised 09/12/01, 6/24/03, 07/14/04, 08/08/06, 06/30/2007, 7/12/2008, 6/23/2011 (One Revision Requiring Constitution change), 07/05/2012, 07/11/2013, 7/10/2014, 6/25/2015, 6/30/2016, 7/13/2017

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

FLORIDA PHARMACY ASSOCIATION HOUSE OF DELEGATES BYLAWS ARTICLE I Name: The name of this body, as an official arm of the Florida Pharmacy Association, shall be the House of Delegates to the Florida Pharmacy Association, and shall hereinafter be referred to as the House of Delegates. ARTICLE II Objectives: a. To establish policy positions for the Florida Pharmacy Association. b. To develop for ratification by delegates policy/position statements of the Florida Pharmacy Association. c. To establish better communications between all persons affiliated with the profession of pharmacy in the State of Florida. d. To provide a forum in which persons affiliated with the profession of pharmacy in the state of Florida may find expression on a state level through their local pharmacy associations. ARTICLE III Section 1. Officers and Qualifications The officers of the House of Delegates shall be a speaker, vice-speaker, secretary three directors, and immediate past speaker. The FPA President-Elect shall serve as an ex-officio member of the Board. A. Each person elected as vice-speaker by the House of Delegates must meet the same qualifications of membership in the FPA as required of the delegates to the House of Delegates and must either a. be a Florida licensed pharmacist in good standing with Florida Board of Pharmacy and b. be actively involved in the pharmacy profession in Florida and be a resident of the State of Florida. B. Each person elected as a director by the House of Delegates must meet the same qualifications of membership in the FPA as required of the delegates to the House of Delegates. Section 2. Selection of Officers The Chairperson of the Board of Directors will be the immediate past speaker of the House of Delegates. The Executive Vice President of the Florida Pharmacy Association will assume the office of secretary of the House of Delegates. The vice-speaker and one director will be elected each year at the annual meeting of the House of Delegates, by plurality vote of the delegates present.

Section 3. Term of office The usual term of office of the speaker shall be for one year and coincide with the usual term of the office of the President of the Florida Pharmacy Association. The usual term of office for the vice-speaker shall be for one year and coincide with the usual term of the office of the president-elect of the Florida Pharmacy Association. The usual term of office for the director shall be three years. The term of office for each director shall be such that one director will finish his term of office each year and one director elected each year. Section 4. Assumption of Office All newly elected officers shall take office at the last session of the House of Delegates Annual Meeting. The vicespeaker shall assume the duties of the speaker at the end of the last session of the House of Delegates of the year following election as vice speaker. Section 5. Duties of Officers A. The chairperson shall preside over all meetings of the Board of directors and such other duties as are normally incident to such office. B. The speaker shall preside over all the meetings of the House of Delegates and all meetings of the Board of Directors in the absence of the chairperson. The speaker shall be the spokesperson for the House of Delegates and shall advocate all positions adopted by the House before the Executive Committee. The speaker shall appoint any committee needed to carry on the work of the House of Delegates and shall function as an ex-officio member of each committee. The speaker shall perform all other duties normally incident to such office. The speaker has the ability to select a parliamentarian. C. The vice-speaker shall preside at the meetings of the House of Delegates in the absence or inability of the speaker. The vice-speaker shall perform all other duties normally incident to such office. D. The secretary shall keep a record of the minutes of the meetings of the House of Delegates, a roll of all delegates, and a record of all information and applications from organizations applying for representation in the House of Delegates. The secretary shall keep a record of any funds of the House of Delegates and shall keep any other records and perform such other duties as are normally incident to such an office. JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. E. The directors shall attend all sessions of the House of Delegates unless excused by the Speaker. The directors shall be responsible for monitoring progress on all adopted directives of the House of Delegates; shall assist in the development of policy/position statements of the Florida Pharmacy Association; shall supervise the annual maintenance of the Policy Manual of the House of Delegates; shall oversee the dissemination of all materials relevant to the business of the House of Delegates and other duties as specified by the speaker of the House of Delegates. F. The directors shall meet before the Annual Meeting to accept, accept with modifications, or return the proposed resolutions: 1. proposed resolutions accepted with modifications by the directors shall be sent to the sponsors(s). The sponsor(s) shall have thirty days within which to respond whether they disagree with the modifications. The sponsor(s), should they disagree with the modification shall indicate in writing their disagreement where upon the proposed resolution as originally submitted shall be introduced. Should the sponsor(s) fail to respond the proposed resolution as modified by the board of directors shall be introduced. 2. proposed resolutions returned by the directors to the sponsors shall state the reasons for such return and shall not include such resolution on the House agenda for the consideration of resolutions. Notwithstanding such return the sponsor(s) may introduce the resolution as new business. Items of new business require the consent of a 2/3 majority of the House of Delegates. Section 6. Replacement of Directors In the event of vacancy due to death, resignation, or lapse of FPA membership the unexpired term of a directorship shall be filled by election at the next annual meeting of the House of Delegates. The unexpired term of a directorship may also be filled by election upon the recommendation of the House of Delegates Board of Directors for an unexcused absence from a session or sessions of the House of Delegates and approval by the House of Delegates or by interim appointment by the Speaker of the House until the next annual meeting of the Delegates. ARTICLE IV House Rules: 1. A resolution may be withdrawn without reading of the resolution into business. 2. The reading of the resolution does not require a second. 3. A motion to refer is debatable. 4. No motion to table will be entertained at the final session of the House. 5. The recognition of non-delegates to speak before the House will be at the discretion of the speaker. 6. Candidates for House Board of Directors seats and Vice-Speaker will be given two minutes to “introduce’ themselves to the House before voting at the final 30

FLORIDA PHARMACY TODAY

session of the House. 7. If unit associations or affiliated organizations do not notify the FPA of the number of their membership in order to determine the number of delegates no later than one month before the annual meeting only two delegates will be seated. 8. All delegates must register for the House of Delegates at least 30 days prior to the meeting start date. 9. Amendments must be presented in writing to the Speaker. There are no friendly amendments. 10. Sponsors of items of New Business shall provide copies of the new business item in sufficient quantities for distribution to each delegation of the House prior to the last day of the session. 11. A motion “To Call the Question” will be considered a “vote” unless someone objects. If there is an objection, the motion will be voted on and will require a 2/3 vote to pass. ARTICLE V Procedural Guidelines: 1. The speaker will make a report on the most recent action of the previous year(s) resolutions at the first session of the House. 2. The speaker will follow-up on the most recent action of passed resolutions and provide a progress report to each association 60 days prior to the next year’s resolution deadline. 3. All resolutions emanating from an individual member or group of members must conform to the resolutions format prescribed by the House of Delegates and bear the name(s) of the sponsor(s) at least one (1) of whom must be present at the House of Delegates session to introduce their resolution by reading. Article VI Affiliated and Invited Organizations Organizations entitled to representation in the House of Delegates include affiliated unit associations and invited organizations. These organizations are entitled to voting privileges as defined by Article V, Section 2 of the Florida Pharmacy Association Bylaws. Should an affiliated unit association fail to send delegates to the House of Delegates for two consecutive years, the House of Delegates Board of Directors shall make a determination of the unit association affiliation status. Upon completion of this determination, the House of Delegates Board of Directors may suspend the unit association’s affiliation agreement. A suspended unit association will be recognized as an invited organization and therefore receive correspondence from the Florida Pharmacy Association and be entitled to voting rights. Any unit association which has had its affiliation with the FPA suspended may submit a written statement expressing its desire to reactivate its affiliation with the FPA at which

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership. time the unit association shall revert to affiliated status automatically.

Ex-officio delegates are not seated as part of the invited or affiliated organization delegations

Should an invited organization fail to send delegates to the House of Delegates for two consecutive years, the House of Delegates Board of Directors may suspend the organization. A suspended organization will no longer receive correspondence from the Florida Pharmacy Association and will not be entitled to voting rights.

Ex-officio delegates shall provide to the Speaker of the House of Delegates their name and address at least 30 days prior to the Annual Conference

Any invited organization which has had its voting rights suspended may submit a written statement expressing its desire to be re-seated in the House of Delegates. Those voting rights will automatically be restored if it sends at least one delegate to the next scheduled session of the House of Delegates.

Any past president of the Florida Pharmacy Association who is a member in good standing may qualify as an exofficio delegate Updated: 2003, 2006, 2010, 2013, 2017

Article VII Ex-officio Delegation An ex-officio delegate as defined in this section is entitled to a seat with voting privileges in the House of Delegates and will not be counted in defining the number needed for a quorum.

JOIN TODAY! JULY 2018

“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”

WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •

Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe

Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

Continuing Education Requirements for Florida Pharmacists and Pharmacy Technicians General Continuing Education Requirements Florida licensed pharmacists are required to obtain thirty (30) hours of approved courses of continued professional pharmaceutical education the 24 month period prior to the expiration date of the license. For example approved continuing education courses will need to be completed between October 1, 2017 and September 30, 2019 before the “PS” license expires on September 30, 2019. (64B16-26.103) Ten (10) of the thirty (30) hours of approved courses of continued professional pharmaceutical education must be LIVE continuing education hours. LIVE continuing education is defined as either a live seminar, a live video teleconference, or through an interactive computer based application. (64B16-26.103) Medication Error Continuing Education Requirements As a part of the biennial renewal, pharmacists are required to complete a two (2) hour Florida Board of Pharmacy approved course on Medication Errors. The course must contain the following components: (a) root-cause analysis; (b) error reduction and prevention; (c) patient safety. The two-hour program may be applied towards the thirty-hour continuing education requirement. (64B16-26.103) Validation and Counseling of Prescriptions for Controlled Substances and Opioids As a part of the biennial renewal, pharmacists are required to complete a two (2) hour Florida Board of Pharmacy approved course on Validation of Controlled Substance Prescriptions. The course must contain the following components: (a) Ensuring access to controlled substances for all patients with a valid prescription; (b) Use of the Prescription Drug Monitoring Program s Database; (c) Assessment of prescriptions for appropriate therapeutic value; (d) Detection of prescriptions not based on a legitimate medical purpose; (e) The laws and rules related to the prescribing and dispensing of controlled substances, (f) proper patient storage and disposal of controlled substances; (g) Protocols for addressing and resolving problems recognized during the drug utilization review to include but not limited to the following: 1. Drug/drug interactions; 2. Side effects; 3. High dose/low dose guidelines; (h) Education on the provision of section 381.887, F.S., Emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone (eff. May 19, 2017) for as long as the Order is valid and effective; (i) Pharmacist initiated counseling of patients with opioid prescriptions; and (j) Available treatment resources for opioid physical dependence, addiction, misuse, or abuse. The twohour program may be applied towards the thirty-hour continuing education requirement. (64B16-27.831 F.A.C.) HIV/AIDS Continuing Education Requirements Effective July 1, 2006, applicants for licensure are no lon-

ger required by Chapter 456, FS, to show proof of a course on HIV/AIDS as part of the initial licensure process. You will, however, be required by Chapter 456, FS, to take an HIV/AIDS course approved by the board for your first renewal. This includes pharmacy technicians as well. As of July 1, 2006 licensees will no longer be required by Chapter 456, FS, to take an HIV/AIDS course for each renewal.

Consultant Re-Certification Continuing Education Requirements

Florida licensed consultant pharmacists must complete no less than 24 hours of Board approved consultant continuing education (see rule 64B16-26.302) with in the 24 month period prior to the expiration date of the consultant license (see 64B16-26.103). For example Florida approved consultant CE programs must be completed between January 1, 2017 and December 31, 2018 for consultant licenses that expires December 31, 2018. Course content for consultant re-certification programs must consist of at least three (3) hours of training in specified subjects. Duplicated courses are not acceptable. (see rule 64B16-26.302).

Ordering and Evaluation of Laboratory Tests

Florida Consultant pharmacists and pharmacists holding the Doctor of Pharmacy degree that wish to order and evaluate laboratory tests and who are practicing under the provisions of Florida Statute 465.0125* are required to complete at least a three (3) hour initial certification course and at least a one (1) hour recertification course. Successful completion of the course will certify the pharmacist for this practice for two (2) years from the date of completion. (64B16-26.320) *Florida Statute 465.0125 defines practice settings as nursing homes or licensed home health agencies for Consultant Pharmacists and only licensed home health agencies for the Doctor of Pharmacy.

Nuclear Pharmacy Continuing Education Requirements

Florida Nuclear Pharmacists must complete no less than twenty-four (24) additional hours of coursework each two year period designed to provide in-depth treatment of nuclear pharmacy practice. (64B16-26.304)

Immunizing Pharmacists

Pharmacists wishing to provide immunizations must take a Board approved immunization training program. The program must be at least 20 hours in length and include a review of immunization laws and CPR training. (64B16-26.1031). During the 2012 legislative session, House bill 509 passed that created a new requirement for pharmacists who wish to maintain their immunization registry. Those requirements include the following: The 3 hour CE program must be done once each biennial renewal period ending September 30 and must be offered JULY 2018

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

by a Florida statewide professional association of physicians; The statewide association must be accredited to provide AMA PRA Category I CME; The program must cover the safe and effective administration of vaccines and epinephrine auto-injection; A distance learning format allowed for the 3 hour CE program; The 3 hours required to meet immunization “recertification” can be included within the 30 hour CE biennial requirement for pharmacists; Failure to get the recertification CE will result in the pharmacist’s immunization registry being revoked.

Registered Pharmacy Technician

Third Quarter 2018: Pharmacy Time Capsule 1993 ACPE released proposed standards and guidelines for the PharmD as the professional entry-level degree. New Mexico passed legislation to address a shortage of primary care providers making it the first state to let specially trained pharmacists provide primary patient care. 1968 Fentanyl, developed by Janssen and marketed by McNeil, was approved as an IV analgesic

Beginning January 1, 2011 technicians interested in working in Florida permitted pharmacies will need to complete a Florida Board of Pharmacy approved training program. Upon successful completion of that program technicians can then submit an application to the Board for full registration status. Registered pharmacy technicians must complete 20 hours of appropriate CE (4 hours live, 2 hours med errors and 1 hour HIV for initial renewal) by December 31, 2018. See rule 64B1626.355 and Florida Statutes 465.014.

1943 Bulletin of the American Society of Hospital Pharmacists first published. Later renamed American Journal of Health-System Pharmacy.

Credit for any Continuing Education Course may not be used more than once in any given year. The above information should only be used as a guide and cannot be considered advice. This information is subject to change.

One of a series contributed by the American Institute of the History of Pharmacy, a unique non-profit society dedicated to assuring that the contributions of your profession endure as a part of America’s history. Membership offers the satisfaction of helping continue this work on behalf of pharmacy, and brings five or more historical publications to your door each year. To learn more, check out: www.aihp.org

FLORIDA PHARMACY TODAY

1918 Beginning of the Spanish flu pandemic. 1893 New Mexico formed state pharmacy association By Dennis B. Worthen, PhD, Cincinnati, OH

HANDBOOK OF ASSOCIATION INFORMATION Information you need to participate and take advantage of your FPA membership.

Continuing Education Calendar 2018-19 LIVE FPA CONTINUING EDUCATION CALENDAR JULY 21-28, 2018 Southern Caribbean Royal Caribbean’s Freedom of the Seas • 10 hrs General Credit available • Departure and returning port: San Juan, Puerto Rico • Ports: Charlotte Amalie, St. Thomas; Willemstad, Curacao; Oranjestad, Aruba; Bassseterre, St. Kitts AUGUST 5-8, 2018 35th Annual Southeastern Gatherin’ The Henderson Beach & Spa Resort Destin, Florida • Room Rate: $189 and up plus tax • Call (855) 741-2777 by July 5, 2018 • General & Consultant Recertification Credit available plus 2 hr med error and CS • Exhibit and Sponsorship Opportunities Available** SEPTEMBER 8-9, 2018 Clinical Conference Miami Airport Marriott Miami, Florida • Room Rate: $129 plus tax • Call (800) 228-9290 by August 17, 2018 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce OCTOBER 6-7, 2018 MidyearClinical & Nuclear Conference Embassy Suites Lake Buena Vista South Kissimmee, Florida Room Rate: $145 plus tax • Call (407) 597-4000 by Sept. 14, 2018 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce

DECEMBER 1-2, 2018 Regulatory & Law Conference Hyatt Regency Sarasota Sarasota, Florida • Room Rate: $155 and up plus tax • Call (888) 421-1442 by Nov. 10, 2018 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce JANUARY 26-27, 2019 Clinical Conference Hilton Sandestin Golf & Beach Resort Destin, Florida • Room Rate: $144 & up plus tax • Call (850) 267-9500 by January 11, 2019 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce APRIL 6-7, 2019 Regulatory & Law Conference Grand Hyatt Tampa Bay Tampa, Florida • Room Rate: $179 plus tax • Call (813) 874-1234 by March 15, 2019 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce MAY 18-19, 2019 Clinical Conference Marriott Jacksonville Jacksonville, Florida • Room Rate: $94 plus tax • Call (800) 962-9786 by April 29, 2019 • 16 hrs total gce of which 12 hrs for rc plus 2 hour med error and controlled substance ce

JULY 10-14, 2019 129th Annual Meeting & Convention Marriott Harbor Beach Resort & Spa Ft. Lauderdale, Florida Room Rate: $189 and up plus tax • Call (954) 525-4000 by June 21, 2019 • General and Consultant Recertification Credit available plus 2 hr med error and controlled substance • Exhibit and Sponsorship Opportunities ONLINE HOME STUDY COURSES • 3 Hour Consultant Credit Hypertenstion • 3 Hour Consultant Credit Diabetes • 3 Hour Consultant Credit Lipids • 3 Hour Consultant Credit IBS/IBD • 3 Hour Consultant Credit Hepatitis • 3 Hour Consultant Credit Asthma • 6 Hour Consultant Credit Geriatric

• 3 hour immunization AMA PR1 course • 2 hour board approved medication errors

• 2 hour board approved validation of CS • 1 hour board approved HIV/AIDS update

JULY 2018

florida BUYER’S GUIDE PHARMACY TODAY

ADVERTISERS: This is a special section designed to give your company more exposure and to act as an easy reference for the pharmacist.

PHARMACY RESOURCES PPSC Retail Pharmacy Purchasing Program (888) 778-9909

LEGAL ASSISTANCE Kahan & Associates, PLLC Brian A. Kahan, R.Ph., Attorney at Law (561) 392-9000 The Health Law Firm George F. Indest III, J.D., M.P.A., LL.M. (407) 331-6620

PHARMACEUTICAL WHOLESALER McKesson Drug Company Jim Springer (800) 804-4590 FAX: (863) 616-2953

Advertising in Florida Pharmacy Today Display Advertising: please call (850) 264-5111 for a media kit and rate sheet. Buyers’ Guide: A signed insertion of at least 3X per year, 1/3 page or larger display ad, earns a placement in the Buyers’ Guide. A screened ad is furnished at additional cost to the advertiser. Professional Referral Ads: FPA Members: $50 per 50 words; Non‑members: $100 per 50 words; No discounts for advertising agencies. All Professional Referral ads must be paid in advance, at the time of ad receipt. 36

FLORIDA PHARMACY TODAY

FREQUENTLY CALLED NUMBERS AHCA MEDICAID PHARMACY SERVICES 2727 Mahan Drive Tallahassee, FL 32308 (850) 412-4166 www.fdhc.state.fl.us/medicaid/ pharmacy AMERICAN PHARMACISTS ASSOCIATION (APhA) Washington, D.C. (800) 237-2742 www.pharmacist.com AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS Bethesda, MD (301) 657-3000 www.ashp.com/main.htm DRUG INFORMATION CENTER Palm Beach Atlantic University (561) 803-2728 druginfocenter@pba.edu FLORIDA BOARD OF PHARMACY 4052 Bald Cypress Way Bin #C04 Tallahassee, FL 32399-3254 (850) 245-4292 www.doh.state.fl.us/mqa FLORIDA POISON INFORMATION CENTER NETWORK (800) 222-1222 www.fpicn.org NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 100 Daingerfield Road Alexandria, VA 22314 (703) 683-8200 (703) 683-3619 fax info@ncpanet.org RECOVERING PHARMACISTS NETWORK OF FLORIDA (407) 257-6606 “Pharmacists Helping Pharmacists”